Following infection of dissociated embryonic day 13 rat medullary raphe cells with a retrovirus encoding the temperaturesensitive mutant of SV40 large T-antigen (T-ag), a neuronal cell line, RN46A, was cloned by serial dilution. At 33"C, RN46A cells express nuclear T-ag immunoreactivity and divide with a doubling time of 9 hr. Undifferentiated RN46A cells express low levels of neuron-specific enolase (NSE) and low (NF-L)-and medium (NF-M)-but not high (NF-H)-molecular-weight neurofilament proteins. Under differentiation conditions, RN46A cells cease dividing, take on a neuronal morphology, and express enhanced levels of NSE and all three NF proteins. Elevation of intracellular CAMP levels increases neurofilament protein expression, whereas activators of various other intracellular second messenger systems have no effect. Differentiated RN46A cells express low-affinity nerve growth factor (NGF) receptor (~75~~~~) and are immunoreactive using an antibody that recognizes the carboxy-terminal 13 amino acids of all three trk proteins (pan-trk).
Both immunoreactivities could be potentiated by treatment with brainderived neurotrophic factor (BDNF), NGF, and adrenocorticotropic hormone, fragment 4-l 0 (ACTH,,,) . Differentiated RN46A cells express low levels of tryptophan hydroxylase (TPH) immunoreactivity, which could be enhanced by treatment with ACTH,,,, BDNF, or NGF. Much of our understanding of the molecular mechanisms that control the development and regenerative capacity of neurons in both the CNS and PNS derives from in vitro studies using neuronal cell lines. However, these are transformed cell lines of peripheral or unknown cellular origin, which often only partially express specific physiological properties of primary CNS neurons. Recent approaches have enabled the proliferation of neuronal cell populations or the development of neuronal cell lines from CNS neuroepithelial precursors or specific postmitotic neurons. Expansion of CNS stem cells has enabled isolation of populations of dividing CNS neuronal precursors (Reynolds and Weiss, 1992; Reynolds et al., 1992; Ray et al., 1993) . As these populations contain both neuronal and non-neuronal precursors, they should prove useful to delineate factors that regulate cell lineage decisions. Neuronal cell lines have also been developed from transgenic mice in which neuronal specific promoters drive viral oncogenes (Hammang et al., 1990; Mellon et al., 1990; Largent et al., 1993; Suri et al., 1993) . This approach allows targeted immortalization of specific neuronal populations, and they have been utilized in studies to determine the regulation of neurohormonal release (Martinez de la Escalera et al., 1992a,b) and to ameliorate genetic deficits in viva (Miller et al., 1993) . Somatic cell hybrids of primary CNS neurons fused to an immortalized neuronal cell line have generated cell lines that retain many properties of primary CNS neurons (Hammond et al., 1986; Lee et al., 1990; Wood et al., 1990; Choi et al., 199 1; Blusztajn et al., 1992; Cashman et al., 1992; Crawford et al., 1992) . Neurotransmitter synthesis has been detected in the majority of these cell lines, indicating the relatively mature neuronal phenotype that these cells can attain in vitro. However, these cell lines are tumorigenic and cannot be used in transplantation experiments.
Retroviral transduction ofCNS neuroepithelial precursors with constructs encoding various oncogenes has been used to isolate neuronal cell lines (DeVitry et al., 1974; Pessac et al., 1983; Casalbore et al., 1987; Bartlett et al., 1988; Frederiksen et al., 1988; Haltmeier and Rohrer, 1990; Ryder et al., 1990; Renfranz et al., 199 1; Bernard et al., 1992; Giordano et al., 1993; Whittemore and White, 1993) . Some investigators utilized regulated transforming proteins, such as temperature-sensitive mutants of SV40 large T-antigen (Frederiksen et al., 1988; Renfranz et al., 1991; Giordano et al., 1993; Whittemore and White, 1993) or Rous sarcoma virus (Pessac et al., 1983) . The advantage of these conditionally immortalized cell lines is that after shifting to nonpermissive temperature, the cells are no longer under the mitotic drive of the oncogene. In principal, these cell lines will constitutively differentiate in the direction they were headed at the time of infection.
Many of these CNS cell lines are pluripotent and can adopt neuronal or glial phenotypes (Bartlett et al., 1988; Frederiksen et al., 1988; Evrard et al., 1990; Ryder et al., 1990; Renfranz et al., 1991; Bernard et al., 1992) . Others are neuronally restricted yet retain a remarkable plasticity to respond to environmental signals both in vitro (Whittemore and White, 1993) and in vivo (Onifer et al., 1993b) . However, neurotransmitter synthesis has not been documented in these cell lines. Here, we describe the temperature-sensitive neuronal cell line RN46A and delineate distinct intracellular pathways that control neurofilament expression and S-HT synthesis.
Materials and Methods
Chemicals. Primary antisera against the indicated antigens were obtained from the following sources: large T-antigen (hybridoma PB 10 1, clone 412) American Type Culture Collection (Rockville, MD); lowaffinity nerve growth factor (NGF) receptor (IgG 192, ~75~~~") , and R 14, respectively) were developed as previously described (Harris et al., 1991) and are commercially available from Chemicon. The following compounds were generously provided by the indicated investigators: acidic fibroblast growth factor (FGF-l), Michael Jaye, RhonePoulenc, Rorer Pharmaceuticals, Inc. (Collegeville, PA); basic FGF (FGF-2) Judith Abraham, Scios, Inc.; NGF, William C. Mobley, University ofcalifornia, San Francisco; brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), neurotrophin-3 (NT-3), and NT-4/5, Ronald Lindsay, Regeneron, Pharmaceuticals, Inc. (Tarrytown, NY): fluoxetine (Eli Lillv). Edith D. Hendlev. Universitv of Vermont. Theretroviral producer i&e psi2tsA58-4 was furnished by Ronald McKay, NIH. Optimem medium (for hybridomas), CNS medium (Kawamoto and Barrett, 1986) , and Geneticin (G4 18) were obtained from GIBCO (Grand Island, NY) , and all other powdered media, attachment factors and chemicals were purchased from Sigma Chemical (St. Louis, MO). Bovine serum albumin was obtained from Sigma and Calbiochem (La Jolla, CA), fetal bovine serum (FBS) from Hyclone (Logan, UT), and tissue culture plasticware from various commercial suppliers.
Isolation of the RN46A cell line. Medullary raphe nucleus was discretely dissected from embryonic day 13 Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA). Preparation of cell suspensions and infection with retrovirus were done as previously described (Whittemore and White, 1993) . The resulting G418-resistant colonies were isolated and expanded in CNS medium, 10% FBS, 250 &ml G418. The cell line RN46 was subcloned by limiting dilution to produce the clonal line RN46A. Southern blot analysis confirmed that the cell line was clonal and indicated a single viral integration site (data not shown).
Cell culture. At permissive temperature (33"Q cells were grown in CNS, 10% FBS, 250 &ml G418. If the cells were to be subsequently differentiated, they were seeded on collagen/fibronectin (100 &cm2 airdried type I rat tail collagen followed by 1 r.&cm* fibronectin). No apparent differences were seen between RN46A cells grown at 33°C on either untreated tissue culture plastic or the collagen/fibronectin substrate. To differentiate RN46A cells, 75% confluent cells were shifted to 39°C (nonpermissive temperature) and the medium changed to 50% DMEM, 50% Ham's F12 (D/F) containing 1% (w/v) bovine serum albumin (BSA) and serum-free medium components modified from Bottenstein and Sato (1979) . These components were 1 pg/ml bovine transferrin, 5 Kg/ml bovine insulin, 100 nM putrescine, and 20 nM progesterone. For most experiments, the RN46A cells were differentiated for 8 d. For the experiments quantifying the expression of p75NGFR, TPH, AAAD, and 5-HT immunoreactivities, RN46A cells were grown on eight-chamber Nunc Lab-Tek slides coated as described above.
Zmmunohistochemistry. NF, glial fibrillary acidic protein (GFAP), galactocerebroside (Gal C), NSE, and ~75 NGFR immunoreactivities were determined as described previously (Sweetnam et al., 199 1; Whittemore and White. 1993 ). For T-aa immunoreactivitv. the cells were fixed with 4% paraformaldehyde (PF jin 0.01 M phosphate buffer (PB), rinsed three times with PB, and incubated with 0.1% Triton X-100. Conditioned medium from the hybridoma (PB 10 1, clone 4 12) was used undiluted. After three rinses with PB, fluorescein-labeled goat anti-mouse IgG (Cappel-Organon Teknika, Malvem, PA) was added. The resulting fluorescence was observed and photographed with a Zeiss IM inverted microscope. For pan-trk immunoreactivity, the cells were fixed with a modified Zamboni's fixative (Holets et al., 1988) containing 1% glutaraldehyde. For AAAD immunoreactivity, the cells were fixed in 4% PF in 0.0 1 M PB; for TPH immunoreactivity, RN46A cells were fixed with 4% paraformaldehyde, 2% glutaraldehyde in 0.01 M PB; for serotonin immunoreactivity, the cells were fixed with modified Zamboni's fixative. After fixation, the monolayers were rinsed three times with PB, incubated with 0.1% Triton X-100, and incubated with pan-trk, TPH, or serotonin antibodies, respectively. The cells were then incubated with the appropriate secondary antibody labeled with avidin-biotin using the Vectastain ABC method according to the manufacturer's directions (Vector Laboratories, Burlingame, CA). These experiments were photographed with a Zeiss Axiophot microscope.
Effect of pharmacological agents on NF-M expression. Pharmacological agents were added to differentiating RN46A cells after 4 d at nonpermissive temperature. The rationale for this treatment paradigm was that preliminary studies had shown that these agents were ineffective if used before the cells had grown for at least 4 d under differentiating conditions. The cells were treated with the agents for 3 d, at which time thev were fixed and assessed for NF-M immunoreactivitv. The followina compounds were added at the concentrations indicated10 PM dibuty$ cyclic AMP (dbcAMP); NGF, FGF-1, FGF-2 at 25 &ml; 10 nM phorbol 12-myristate 1 S-acetate (PMA); 5 U/ml granulocyte-macrophage colony-stimulating factor (GM-CSF); 100 no calcium ionophore A23 187; and 10 /LM retinoic acid. These concentrations were chosen based on effective ranges cited in the literature. Untreated cells served as controls. Each experiment was run in duplicate with a total of four experiments. Upon completion of immunostaining, a random field from each of the duplicate wells was photographed and the number of positive and negative cells counted by an observer who was unaware ofwhich conditions were being quantified. The percentage of NF-M-positive cells was subsequently calculated and the overall statistical significance was determined as described below.
Effect of the time of initiation and duration offorskolin treatment on NF-L, NF-M, and NF-H expression. Forskolin (1 PM) was added to RN46A cells for the following intervals indicated by days after shift to differentiating conditions: untreated, days 4-8, 5-8, 6-8, 7-8, 5-6, 5-7, and days 6-7. On day 8, the cells were fixed and analyzed for NF-L, NF-M, and NF-H immunoreactivities. Random fields from four separate experiments were photographed and coded, and the percentage of NF-positive cells counted by an observer who was unaware of which conditions were being quantified. After breaking the code, the statistical significance of the resultant data was evaluated as described below.
Efects of pharmacological agents on p7JNGFR, pan-trk, AAAD, and TPH expression. After 4 d under differentiating conditions, RN46A cells were left untreated or treated for 4 additional days with the following agents: 10 nM ACTH,,, (Met-Glu-His-Phe-Arg-Trp-Gly); 0.1 in.4 aldosterone; 1 nM dexamethasone; 1 PM forskolini 1 U/ml GM-CSF: 0.1 nM corticosterone: 0.1% rat serum: BDNF. CNTF. NT-3. NT-4/5, kpidermal cell growth factor (EGF), FGF-1, and FGF-2 were used at 25 @ml. After 8 d, the RN46A cells were qualitatively evaluated for p75NCFR, pan-trk, AAAD, or TPH immunoreactivities.
Eflect of BDNF and KC1 on TPH and serotonin expression. To examine whether there is an interaction between partial depolarization and neurotrophins on the enhancement of the serotonergic phenotype, RN46A cells were differentiated for 8 d at 39°C in the absence ofeffectors (media), for 8 d in medium containing 50 r&ml BDNF (BDNF), for 8 d in medium containing 50 rig/ml BDNF to which 40 mM KC1 was added during the last 4 d in culture (BDNF/KCl), for 8 d in medium . Effect of pharmacological agents on NF-M expression. Pharmacological agents were added to differentiating RN46A cells after 4 d at 39°C. The cells were treated for 3 d, at which time they were fixed and assessed for NF-M immunoreactivity. A random field from each of duplicate wells was photographed and the number of positive and negative cells counted. Control cells were untreated. d&IMP, 10 PM dibutyryl cyclic AMP; NGF, 25 r&ml nerve growth factor; FGF-I, 25 &ml acidic fibroblast growth factor; FGF-2, 25 rig/ml basic fibroblast growth factor; PMA, 1 nM phorbol 12-myristate 13-acetate; GM-CSF, 5 U/ml granulocyte-macrophage colony-stimulating factor. A23187 and retinoic acidwere used at 100 nM and 10 PM, respectively. Data represent the mean * SEM of the number of independent experiments indicated in the respective bars. Only the effect of dbcAMP was significant [overall ANOVA: F(8,60) = 6.87, p < 0.001; unequal N LSD post hoc test for dbcAMP: p i O.OOl].
containing 40 mM KC1 (KCl), or for 8 d in medium containing 40 mM KC1 to which 50 @ml BDNF was added during the last 4 d in culture (KCl/BDNF). The medium and any additional components were replaced every second day. On day 8, the cells were rinsed and incubated for 60 min with 10 WM L-tryptophan and 30 min with 10 WM each clorgyline and fluoxetine, and the expression of TPH and serotonin was immunohistochemically assessed. For TPH, a fluorescein-labeled secondary antibody was used, and for serotonin, an avidin-biotin-peroxidase reporter was used to visualize immunoreactivity.
To quantify the expression of TPH and 5-HT under these various conditions, images of the stained cells were captured on video with IMAGE 1 software (Universal Imaging Corp., West Chester, PA) and sorted by staining intensity into one of four groups. The total numerical density, 255 pixels, was divided into four ranges of density (O-64 pixels, none or minimal staining intensity; 65-l 29 pixels, low staining intensity; 130-l 95 pixels, moderate staining intensity; and 196-255 pixels, maximal staining intensity), each range corresponding to a pseudocolor. This analysis allows quantitation of the number of cells expressing variable levels of immunoreactivities and reflects TPH or 5-HT synthesis in the entire population of differentiating RN46A cells. In each field of cells, the number of cells corresponding to each pseudocolor group was counted. Background was initially subtracted using a slide identically stained with nonimmune IgGs and the background subtraction subroutine program on IMAGE 1 software. All slides, both bright field and fluorescent, were analyzed under identical lighting conditions. The antigens that were detected with the ABC secondary antibodies were processed with identical development times with the peroxidase substrate. For each condition, 500-1000 cells were counted from at least eight random fields from each of three independent experiments (1500-3000 total cells). Statistical significance was determined as described below.
HPLC measurement of 5-HT levels. RN46A cells were differentiated in six-well Costar tissue culture plates with no additions (media), BDNF, or BDNF/KCl as described above. One hour prior to harvesting the cells, they were incubated with 10 PM L-tryptophan, and 30 min later fluoxetine and clorgyline were added to 10 PM. After incubation for an additional 30 min, cells were gently scraped off the tissue culture plate in 2 ml of PBS and a 100 ~1 was aliquot removed for protein determination by the Micro BCA Protein Assay (Pierce, Rockford, IL). The remainder of the cells were pelleted at 4°C. Following removal of the supernatant, HPLC buffer (0.1 M acetic acid in 2% EtOH) was added to bring the protein concentration to 2 mg/ml. Samples were sonicated, centrifuged at 13,000 x g for 15 min at 4°C and 50 ~1 aliquots of the supematants snap frozen in liquid nitrogen for subsequent HPLC analysis. Concentrations of serotonin were determined by reverse-phase isocratic liquid chromatography with electrochemical detection, as described previously (Globus et al., 1992) .
Statistical analysis. The statistical significance of all quantitative data was determined with a multivariate analysis of variance (MANOVA).
Comparisons of differences between individual means were tested using the Tukey honest significant difference (HSD) method or the unequal N least significant difference (LSD) test. All of the analyses were performed with a commercially available software package (STATISTICA, Statsoft, 1990) .
Results

Morphology of RN46A cells and the expression of cell-specific antigens
At 33"C, RN46A cells divide with a doubling time of 9 hr, have a fibroblast-like morphology (Fig. lA) , and express nuclear T-ag immunoreactivity (Fig. 1B) and low levels of NSE (Fig. 1C) . Undifferentiated RN46A cells were immunopositive for NF-L and NF-M, although NF-H immunoreactivity could not be detected. The NF-L and NF-M immunoreactivities were located perinuclearly in the cytoplasm (see Fig. 3A-C) . When RN46A cells are shifted to differentiating conditions, the cells cease dividing and appear neuronal, extending long, sometimes multipolar processes (Fig. 1D) . Nuclear T-ag immunoreactivity is absent or greatly reduced (Fig. lE) , while NSE immunoreactivity is markedly increased (Fig. IF) . Subpopulations of differ- proteins, although few NF-H-positive cells were seen (see Fig.  3D-F) . Under no conditions were the glial antigens GFAP or GalC detected in RN46A cells (data not shown).
Dibutyryl CAMP enhances NF-M expression in d@erentiating R N46A cells A number of pharmacological agents that activate various intracellular second messenger systems were tested for their effects on RN46A cell differentiation. As an initial qualitative screen, the expression of NF-M immunoreactivity was used as an index of neuronal differentiation, both to allow assessment of enhanced NF-M synthesis and to delineate the potential induction of neuritic outgrowth and/or branching. NF-M appears early in neuronal development and its expression is a sensitive indicator of the initial progression of neuronal differentiation. Treatment with dbcAMP significantly enhanced (2.1 -fold, p < 0.00 1) the number of differentiated RN46A cells that expressed NF-M (Fig. 2) . NGF, FGF-1, FGF-2, PMA, GM-CSF, A23187, and retinoic acid were all ineffective in increasing the number of NF-M positive RN46A cells.
Temporal regulation of NF expression by forskolin in d$erentiating RN46A cells
Initial results demonstrated that dbcAMP and forskolin treatment resulted in identical induction of NF-M expression in RN46A cells and subsequent studies were undertaken with forskolin. Treatment of RN46A cells with forskolin between days O-4 after shifting to differentiating conditions did not enhance NF-M expression (data not shown). However, increasing intracellular CAMP levels between days 4 and 8 of differentiation markedly enhanced NF-M expression (Fig. 3H) as well as NF-L (Fig. 3G ) and, to a lesser extent, NF-H (Fig. 31) . Therefore, experiments were designed to determine if a critical period of RN46A cell differentiation existed, during which enhanced intracellular CAMP levels would maximally potentiate NF expression and/or assembly. RN46A cells were treated with 1 PM forskolin for varying intervals after the shift to differentiating conditions and assessed for the expression of NF-L, NF-M, and NF-H immunoreactivities. A significant increase, 48% above control, in the number of NF-L-positive RN46A cells was only seen following addition of forskolin on day 4 and maintained between days 4 and 8 (Fig. 4 , open bars). Small changes that did not exceed 3 1% above control were observed with forskolin treatment at later times, but these differences were not statistically significant. In contrast, forskolin treatment of differentiating RN46A cells for all time periods after day 4 significantly increased the number of NF-M-positive cells (Fig. 4, crosshatched bars) . Maximal effects were seen between days 4-8 (118.1% above control), but even 24 hr treatment on days 6-7 (60.0%) or 7-8 (57.2%) also significantly enhanced NF-M levels. The number of NF-H-positive RN46A cells was also increased by forskolin treatment (Fig.  4 , solid bars), with maximal effects seen following differentiation in forskolin for days 4-8 (144.4% above control). Similar to results seen with NF-M, most of the treatment paradigms were effective, the exceptions being days 5-8. However, as this value was 85.6% above control and approached statistical significance (p = 0.06) a larger sample size may have given significant differences. Overall, forskolin treatment resulted in a greater percentage of total NF-M-positive RN46A cells compared to the number of either NF-L-or NF-H-positive cells [F(7,416) = 25.54, p -c O.OOl]. Interestingly, forskolin not only increases the expression of the neurofilament proteins but also affected NF distribution (Fig. 3) . Differentiated RN46A cells exhibit a predominantly perinuclear localization of NF-L and NF-M immunoreactivities, although NF-M immunoreactivity can readily be detected in the proximal end of the neurites (Fig. 3D,E) . Treatment with forskolin increased the amount of all three NF proteins and led to an intracellular redistribution of these proteins into the cell processes (Fig. 3GJZ) . This was especially apparent with NF-M, where forskolin treatment resulted in NF-M expression in nearly all RN46A cells. While forskolin increased NF-H expression, it did so to a much lower extent than for NF-L and NF-M (compare Fig. 31 with 3G,H) .
Regulation of p7YCFR, pan-trk, AAAD, and TPH expression
Initial experiments demonstrated that differentiating RN46A cells expressed p75NGFR, pan-trk, and AAAD immunoreactivities (data not shown), as well as that for TPH (Fig. 5A ). In attempts to define possible extracellular effecters that might enhance the expression of these proteins and, hence, maximize potential serotonergic properties, a variety of pharmacological agents were tested on differentiating RN46A cells (Table 1 ). The expression of low-and high-affinity neurotrophin receptors P75 NGFR and pan-trk, respectively, was potentiated by ACTH, 10, BDNF, and NGF. Dexamethasone only slightly enhanced pan-trk expression but did not effect ~75~~~~ levels. Interestingly, forskolin only slightly increased ~75~~~~ but did not increase the number of pan-trk positive cells. One percent rat serum slightly enhanced the levels of both proteins, while aldosterone, corticosterone, CNTF, NT-3, NT-415, EGF, GM-CSF, FGF-1, and FGF-2 were without effect. AC-W-,,, BDNF, and NGF also increased the number of RN46A cells that expressed the enzymes necessary for 5-HT synthesis, TPH and AAAD. Dexamethasone increased TPH without affecting AAAD, while rat serum slightly increased TPH immunoreactivity. These results do not reflect increased proliferation as there was no incorporation of 5-bromo-2'-deox- Temporal interaction of BDNF and KCI in potentiating TPH and 5-HT expression The presence of both TPH and AAAD immunoreactivities in a subset of differentiating RN46A cells strongly suggested that RN46A cells were serotonergic. Under basal differentiating conditions, very few RN46A cells were S-HT positive (Fig. 5D) , despite readily detected expression of TPH immunoreactivity (Fig. 54) . Differentiating RN46A cells with BDNF markedly enhanced TPH expression (Fig. 5B, Table l ), but did not appear to increase the number of 5-HT-positive cells (Fig. 5E) . Previous studies have suggested that growth factors and partial depolarizing conditions can interact to regulate neuronal differentiation (Bin-en et al., 1992; Rao et al., 1992; Sun et al., 1992) . We investigated the potential combined effects of partial depolarizing conditions and BDNF on the serotonergic properties of RN46A cells. RN46A cells differentiated in the presence of BDNF for days O-8 with concurrent culture in 40 mM KC1 for days 4-8 (BDNF/KCl) showed marked enhancement of both TPH (Fig. 5C ) and 5-HT (Fig. 5F) immunoreactivities.
Quantitative image analysis showed that BDNFcaused a fourfold (p < 0.02) increase in the number of high fluorescence intensity TPH-immunoreactive RN46A cells (Fig. 6A) . Differentiating the cells with BDNF/KCl shifted the distribution of TPH fluorescence intensities such that sevenfold (p < 0.001) more RN46A cells showed high levels of TPH immunoreactivity. RN46A cells cultured in KC1 or KCVBDNF did not increase TPH immunoreactivity above control levels. If the RN46A cells were differentiated in BDNF, KCl, or KCl/BDNF, no significant differences in the number of high-5-HT-expressing cells were detected from that seen in media alone. Robust increases in 5-HT immunoreactivity (Fig. 6B ) were only seen with BDNF/ KCl, as the population of immunopositive cells was markedly shifted 8.5-fold (p < 0.001) toward high immunoreactive levels. Culturing with KC1 did decrease the number of RN46A cells in the minimal 5-HT-immunoreactive group, irrespective of whether BDNF was present. These data suggest that the low levels of TPH seen in RN46A cells differentiated in the absence of BDNF were being activated by the partial depolarization, resulting in cells with slightly higher levels of 5-HT. However, the number of RN46A cells in the high 5-HT immunoreactivity group was only increased if BDNF treatment was followed by depolarizing conditions. In addition, differentiating RN46A cells in the presence of KC1 resulted in an altered cellular morphology. The neuritic extensions were much longer and the cell somata more elongate (compare Fig. 5C ,F with SA,B,D,E). This altered morphology was independent of the increases in TPH and 5-HT immunoreactivities, as it occurred when RN46A cells were differentiated in KC1 or KCl/BDNF. As noted above, these two latter conditions do not enhance 5-HT immunoreactivity.
Although not directly quantified, none of the pharmacological agents used in the experiments to examine neurofilament or neurotrophin receptor expression or serotonergic properties appeared to decrease RN46A cell survival.
HPLC detection of 5-HT levels
The quantitative morphological data demonstrating the enhancement of 5-HT synthesis by BDNF and KC1 were substantiated by measuring 5-HT levels by HPLC (Fig. 7) . RN46A cells differentiated in the absence of effecters (media) contained 346.6 f 79.9 pmol of 5-HT/mg protein. RN46A cells differentiated in the presence of BDNF did not increase the levels of 5-HT. However, differentiation of RN46A cells in BDNF/KCl increased 5-HT levels 3.4-fold (p < 0.001) above that seen in media or BDNF alone. Figure 6 . Quantitative assessment of BDNF and KC1 effects on TPH and 5-HT expression. RN46A cells were differentiated for 8 d under the conditions indicated in the code at the bottom of the figure, and described in Materials and Methods. Cells were then immunohistochemically stained for tryptophan hydroxylase (TPH) (A) and serotonin (5-HT) (II). The levels of the respective immunoreactivities in individual cells were quantified by image analysis and sorted into four bins of increasing immunoreactivity from minimal to high as described in Materials and Methods. Data are the mean k SEM of 1500-3000 individual cells for each condition counted from three independent experiments. ANOVA showed that the interaction between treatment groups and labeling intensity groups was highly significant for both TPH [F(12,292) This suggestion is supported by the fact that dividing, undifferThe majority ofthe neuronal CNS cell lines derived by retroviral transduction are pluripotent, with the potential for neuronal and glial differentiation (Bartlett et al., 1988; Frederiksen et al., 1988; Evrard et al., 1990; Ryder et al., 1990; Renfranz et al., 1991; Bernard et al., 1992) . This contrasts with RN46A cells, and the similar raphe-derived RN33B cell line (Whittemore and White, 1993) in which differentiation is constitutive and neuronally restricted. These differences likely reflect the fact that medullary raphe neurogenesis peaks between El 3 and El4 (Lauder and Bloom, 1974) , and the neuroepithelial precursors were comentiated RN46A cells synthesize NSE, NF-L, and NF-M. Bipotential cell lines likely arise when very early neuroepithelial precursors or regions undergoing both neurogenesis and gliogenesis are infected.
In the absence of exogenous pharmacological agents, differentiated RN46A cells expressed NSE, NF-L, NF-M, and little NF-H, as well as vimentin and nestin (data not shown). Vimentin is present early in neuroepithelial cell development, and can coexist with neurofilament proteins as neuronal differentiation initiates. In developing neurons, NF-L and NF-M initially appear and later, NF-H is expressed as the neuron matures (Shaw, 199 1; Nixon and Shea, 1992) . These data would indicate that RN46A cells differentiated in clonal culture are at an early stage of development, and additional effecters are required for more extensive neuronal maturation.
Of the effecters tested, only those that elevated intracellular CAMP levels upregulated neurofilament expression. It is unlikely that the effects of dbcAMP were mediated by the butyrate moiety, as identical results were obtained with forskolin. Moreover, the neurofilament promoters do not contain CAMP-response elements (Elder et al., 1992a,b) , indicating that CAMP is not directly activating neurofilament transcription. These data suggest that CAMP secondarily increased CAMP-dependent protein kinase (PKA) activity, which resulted in enhanced neurofilament expression. Activation of other intracellular second messenger systems were ineffective in increasing NF expression. Although not directly quantified, none of these agents, including dbcAMP, markedly altered neurite outgrowth in RN46A cells. Forskolin treatment upregulated NF-M expression in a similarly derived neuronal cell line RN33B (Whittemore and White, 1993) , suggesting that this mechanism for induction of neurofilament synthesis and altered distribution of the neurofilaments may be a general one in CNS neurons. The initial qualitative screen for pharmacological agents that enhanced RN46A cell differentiation examined a single parameter (NF-M expression). Activation of other signaling pathways are likely to be involved in different aspects of neuronal differentiation (discussed below).
The expression of all three neurofilament proteins was increased by forskolin treatment, although this was most readily seen with NF-M and, to a lesser extent, NF-L. The fact that few NF-H-positive RN46A cells were observed suggests that activation of PKA is alone insufficient to initiate the mature pattern of NF triplet protein expression. These data are consistent with in viva results that demonstrated that NF-H expression occurs subsequent to synaptogenesis, likely in response to an as yet unidentified target-derived signal (Shaw and Weber, 1982, 1983; Patcher and Liem, 1984; Carden et al., 1987) . In addition to differential temporal expression of the three neurofilament proteins during neuronal differentiation, NF-M and NF-H are also differentially phosphorylated during development (Carden et al., 1987; Nixon and Sihag, 199 1; Shaw, 1991) . However, we specifically chose neurofilament antibodies that recognized epitopes in the tail domains of NF-M and NF-H that are minimally affected by the phosphorylation state (Harris et al., 199 1) . This allowed detection of NF-M and NF-H without the complication of differential antigenic recognition of the various phosphoprotein intermediates.
Neurofilament assembly is regulated by a variety of distinct kinase systems. All three neurofilament proteins have multiple phosphorylation sites, with residues in the amino-terminal head domain phosphorylated predominantly by second messengerdependent protein kinases while those in the carboxy-terminal tail domain appear to be mostly second messenger independent (Nixon and Sihag, 1991; Shaw, 1991) . PKA-dependent phosphorylation of NF-L monomers in vitro prevents their assembly, and similar phosphorylation of isolated NF-L filaments results in their disassembly (Hisanga et al., 1990; Nakamura et al., 1990) . How these in vitro results reflect potential regulatory mechanisms in intact neurons is unclear. Present data with RN46A cells suggest that activation of PKA is a necessary prerequisite for enhanced neurofilament synthesis and assembly of both NF-L and NF-M. Whether this activation of PKA sec- ondarily results in direct phosphorylation of the neurofilament proteins as an obligate step for increasing expression and altered intracellular distribution is at present unresolved. However, the catalytic subunit of PKA is closely associated with neurofilament proteins, and this interaction is tightly regulated by CAMP (Dosemeci and Pant, 1992) . Moreover, both NF-L and NF-M have PKA-dependent phosphorylation sites in the head domain that are heavily phosphorylated in the cell soma and are gradually dephosphorylated as the NFs are transported to the distal axon (Black and Lee, 1988; Sihag and Nixon, 1990,199 1) . Thus, present data are consistent with a direct role for PKA-dependent phosphorylation in early intracellular events that regulate NF-L and NF-M synthesis and distribution in RN46A cells.
In contrast, 5-HT synthesis in differentiating RN46A cells is regulated by a different cellular mechanism(s). Both AAAD and TPH immunoreactivities were upregulated by ACTH,,, and BDNF, and unaffected by PKA activation. ACTH,,, has been shown previously to potentiate serotonergic function in primary raphe neurons (Azmitia and de Kloet, 1987) . Maximal numbers of 5-HT-positive RN46A cells were seen following treatment with BDNF/KCl. The HPLC data directly quantifying 5-HT levels confirmed the immunohistochemical data. BDNF/KCl treatment had no effect on the expression or distribution of any of the neurofilament proteins (data not shown), despite the elongated neurites observed in RN46A cells grown under partial depolarizing conditions. BDNF actions are mediated through interaction with and subsequent auto-tyrosine phosphorylation of the tyrosine kinase receptor trkB (Chao, 1992) . RN46A cells contain immunohistochemically detectable levels of trk protein, as identified with an antibody that specifically recognizes the carboxy-terminal 13 amino acids of all three trk proteins (pantrk Ab 203; Hemstead et al., 1992) . While BDNF treatment markedly upregulates pan-trk and TPH expression, NGF also slightly enhanced the levels of these immunoreactivities, sug-gesting the potential presence of trkA as well. While beyond the scope of the present report, ongoing studies are addressing which specific trk protein(s) are activated in RN46A cells.
Previous results have shown that TPH can be activated by Ca2+/calmodulin-dependent protein kinase (CaMK) (BoadleBiber and Phan, 1987; Ehret et al., 1989; Isobe et al., 1991) . Moreover, partial depolarization increases 5-HT levels in brainstem slices (Hamon et al., 1979; Boadle-Biber and Phan, 1986) . This effect could be mimicked by agents that increase intracellular Ca*+ levels (Boadle-Biber, 1979 ) and blocked by replacing extracellular Ca*+ with Co2+ (Hamon et al., 1979) . These authors concluded that the elevated K+ levels were secondarily activating CaMK. A similar mechanism may regulate TPH activity in RN46A cells, as differentiation in KC1 or KCl/BDNF increased the number of moderate or high-intensity 5-HT immunoreactive cells between 1.5 and 2.6-fold, although these increases were not statistically significant. Both BDNF and elevated K+ were required for maximal induction of 5-HT synthesis, and the temporal sequence of these treatments was crucial. BDNF treatment had to precede treatment with elevated K+. Collectively, these results indicate that independent mechanisms control the synthesis (BDNF) and activation (depolarization) of TPH in RN46A cells.
There is precedence for interactions of growth factors and depolarizing conditions in regulating neuronal survival and differentiation, although these interactions have proved to be distinct and cell-type specific. Depolarization increased vasoactive intestinal peptide (VIP) levels in adult sympathetic ganglion neurons grown in the presence of NGF (Sun et al., 1992) . In contrast, elevated K+ blocked the induction of choline acetyltransferase, VIP, substance P, and somatostatin induced by CNTF in newborn sympathetic ganglion neurons . Lastly, in an immortalized sympathoadrenal progenitor cell line, partial depolarization induced trkA expression, allowing the cells to survive and differentiate in the presence of NGF (Buren et al., 1992) . While these examples underscore the complexity of neurotrophic factor interactions with depolarizing conditiotrs in vitro, they reflect similar regulatory events that occur in vivo (Kessler and Black, 1982; Hyatt-Sachs et al., 1993) .
The RN46A cell line should prove to be a useful model of differentiating CNS neurons regarding delineating the molecular mechanisms that control neurofilament assembly and regulate 5-HT synthesis. Furthermore, temperature-sensitive neuronal cell lines have been shown to integrate into host parenchyma following transplantation into the adult (Onifer et al., 1993a,b) and neonatal (Renfranz et al., 1991) CNS. These neuronal cell lines are particularly amenable for transplantation studies because their immunological properties are such that once differentiated, they downregulate cell surface molecules necessary for recognition by cytotoxic T lymphocytes (White et al., 1994) . Given a clear understanding of the mechanisms that underlie the neuronal differentiation of RN46A cells in vitro, these cells may ultimately prove useful to replace lost serotonergic neurons in vivo.
